News & Reports 2018-03-22T10:04:39+00:00

Have some news you want to share with the Oregon Bio community?  Fill out our submission form.

AbSci Establishes New Collaboration with Sanofi

AbSci and Sanofi entered into a collaboration to improve the manufacturability for two of Sanofi’s biotherapeutics
VANCOUVER, Wash., Jan. 9, 2019 /PRNewswire/

AbSci, a global leader in biotherapeutic discovery and manufacturing technologies, today announced a collaboration with Sanofi. Under the terms of the agreement, AbSci will apply its breakthrough E.coli manufacturing platform, SoluProTM, and its novel optimization assay system, to two of Sanofi’s biotherapeutic molecules. AbSci’s proprietary technology platform is designed with the ability […]

January 18th, 2019|

Veana Therapeutics secures NIH funding for VIMO

Veana Therapeutics is pleased to announce a Phase I Small Business Innovation Research (SBIR) grant award from the NIH National Cancer Institute to conduct proof-of-concept pre-clinical studies of its lead product, VIMO (Veana Immune Modulator) in combination with immune checkpoint inhibitors in triple negative breast cancer. Learn more about Veana here.

November 12th, 2018|

DesignMedix Inc. wins PBJ’s Manufacturer of the Year (1-10 employees)

By Denise Szott – Contributing writer for Portland Business Journal

The Portland company developed a drug to cure malaria that is easy and cheap to manufacture

DesignMedix co-founder and Chief Scientific Officer David Peyton and a student carry out research at the DesignMedix Lab in the Portland State


Most of us have felt annoyed […]

November 12th, 2018|

How a $600M jolt could get OHSU’s promising AIDS vaccine to market

Elizabeth Hayes, Portland Business Journal


When TomegaVax Inc. spun out from Oregon Health & Science University in 2011, it had the makings of a future bio-star.

The startup would commercialize the research from the OHSU Vaccine and Gene Therapy Institute, where Dr. Louis Picker and his colleagues were developing a vaccine to combat some […]

June 15th, 2018|


A new government program was supposed to prevent certain Medicare recipients from cycling in and out of hospitals. Now some experts worry it may be costing lives. [...]

Verily, the Alphabet research division formerly known as Google Life Sciences, has received a 510(k) clearance from the FDA for its own clinical study smartwatch, complete with an on-demand ECG. But a [...]

An Eli Lilly drug on the market for a rare form of cancer is now in limbo, after it failed a trial needed to retain the FDA approval the treatment, known as olaratumab (Lartruvo), won two years ago. L [...]

FLAGSTAFF, Ariz. (AP) -- Arizona has become the only state in the country where members of federally recognized tribes are exempt from work or volunteer requirements for Medicaid benefits, while 120,0 [...]

Welcome to Friday's Overnight Health Care.Anti-abortion marchers came to Washington, where the government is divided and still partially shut down. There's also news on Medicaid work require [...]

The outsourcing comes at a difficult time for the state's individual health care market, as insurers drop out of some counties and premiums increase. [...]

Let's catch up with the latest innovation news in Texas. —TeVido, an Austin biotech, has raised $1.2 million to help fund a new facility in which the company can use a patient's own cells to [...]

[Updated 12:35pm ET with comments from Michael Gilman, Obsidian CEO, see below.] Bristol-Myers Squibb's huge proposed buyout of Celgene earlier this month has left many in biotech circles concern [...]